Cyvex Nutrition and Eevia Health announce partnership to bring "extra strength" elderberry extract to the North American marketplace

In a recent press release, Cyvex Nutrition, a member of the Bioriginal Group of Companies, announced that the company had formed a strategic partnership with Eevia Health Plc, to introduce Feno-Sambucus 30, an extra strength, potent, and excipient-free elderberry extract, into the North American market.¹ Elderberry is known for having potential benefits in supporting immune health. Feno-Sambucus 30 contains more than 30% anthocyanins and more than 50% total polyphenols, as well as high levels of proanthocyanidins. Due to its potent formulation, it lowers dosage volumes, which may help manufacturers with cost-efficiency and create new formulations. In vitro testing from an accredited third-party lab has also shown that the extract demonstrates superior bioactivity across 148 human biomarkers.

Feno-Sambucus 30 was crafted through the proprietary extraction and purification process from Eevia Health. According to the company, its process removes nearly all sugars and organic acids. Virtually sugar-free and free of excipients, the extract is a good candidate for clean-label applications. Additionally, the company states that the extract is manufactured in Finland using green-chemistry methods, as well as elderberry cultivated in Europe, giving it one of the lowest carbon footprints in the industry.

“Feno-Sambucus 30 fits perfectly into our mission of delivering nature-made, science-backed ingredients,” said Matt Phillips, president of Cyvex Nutrition.¹ “It’s not just about potency; it’s about delivering purity, sustainability, and validated bioactivity. This partnership allows us to bring those benefits to North American manufacturers developing the next generation of immune health products.”

Reference

1. Cyvex launches extra strength elderberry extract https://cyvex.com/2025/07/22/cyvex-launches-elderberry-extract/ (accessed Jul 23, 2025).